HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a.

Wang, Qinghua; Jiang, Shujun; Song, Anying; Hou, Siyuan; Wu, Qinfeng; Qi, Longju; Gao, Xiang.

Afiliación

Wang Q; State Key Laboratory of Pharmaceutical Biotechnology.
Jiang S; MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing Biomedical Research Institute, Nanjing University, Nanjing.
Song A; Laboratory Animal Center, Nantong University.
Hou S; State Key Laboratory of Pharmaceutical Biotechnology.
Wu Q; MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing Biomedical Research Institute, Nanjing University, Nanjing.
Qi L; State Key Laboratory of Pharmaceutical Biotechnology.
Gao X; MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing Biomedical Research Institute, Nanjing University, Nanjing.

Onco Targets Ther ; 10: 4753-4763, 2017.

Article en En | MEDLINE | ID: mdl-29033588